Published in Diabetes Obes Metab on February 26, 2013
Glucagon-Like Peptide-1 Regulates Cholecystokinin Production in β-Cells to Protect From Apoptosis. Mol Endocrinol (2015) 0.87
New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders. World J Diabetes (2015) 0.76
Glucagon-like peptide-1 and cholecystokinin production and signaling in the pancreatic islet as an adaptive response to obesity. J Diabetes Investig (2016) 0.75
Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell (1992) 12.74
Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetologia (1990) 2.75
The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity (1994) 2.59
Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell (1992) 2.38
Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1. Nat Genet (1999) 2.28
Altered glucose metabolism in microvessels from patients with Alzheimer's disease. Ann Neurol (1989) 2.08
Lipid composition of Saccharomyces cerevisiae as influenced by growth temperature. Biochim Biophys Acta (1972) 1.66
Determining the cost of genital warts: a study from Ireland. Sex Transm Infect (2008) 1.60
Transcranial magnetic stimulation for the treatment of seizures: a controlled study. Neurology (2002) 1.59
Noninvasive imaging by optical coherence tomography to monitor retinal degeneration in the mouse. Invest Ophthalmol Vis Sci (2001) 1.44
Insulin-releasing and insulin-like activity of the traditional anti-diabetic plant Coriandrum sativum (coriander). Br J Nutr (1999) 1.42
Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion. Diabetes (1996) 1.26
Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice. Diabetologia (1981) 1.24
PKC-dependent stimulation of exocytosis by sulfonylureas in pancreatic beta cells. Science (1996) 1.22
Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma. Ann Surg Oncol (2009) 1.14
Cortical localization of reading in normal children: an fMRI language study. Neurology (2001) 1.14
Ocimum sanctum leaf extracts stimulate insulin secretion from perfused pancreas, isolated islets and clonal pancreatic beta-cells. J Endocrinol (2006) 1.14
A multivariate analysis of evoked responses in EEG and MEG data. Neuroimage (1996) 1.13
Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets. Diabetologia (2007) 1.12
Efficient high-resolution genetic mapping of mouse interspersed repetitive sequence PCR products, toward integrated genetic and physical mapping of the mouse genome. Proc Natl Acad Sci U S A (1995) 1.12
Antihyperglycemic actions of Eucalyptus globulus (Eucalyptus) are associated with pancreatic and extra-pancreatic effects in mice. J Nutr (1998) 1.10
Tissue protein synthesis rates in critically ill patients. Crit Care Med (1998) 1.10
Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes. Diabet Med (2005) 1.09
The traditional plant treatment, Sambucus nigra (elder), exhibits insulin-like and insulin-releasing actions in vitro. J Nutr (2000) 1.07
Rett syndrome: a survey of North American patients. J Ment Defic Res (1988) 1.06
Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications. Diabetologia (2009) 1.06
Traditional dietary adjuncts for the treatment of diabetes mellitus. Proc Nutr Soc (1991) 1.04
Mechanisms of amino acid-induced insulin secretion from the glucose-responsive BRIN-BD11 pancreatic B-cell line. J Endocrinol (1996) 1.00
IRE-bubble PCR: a rapid method for efficient and representative amplification of human genomic DNA sequences from complex sources. Genomics (1994) 0.99
An epistatic interaction controls the latency of a transgene-induced mammary tumor. Mamm Genome (2000) 0.99
Ier5, a novel member of the slow-kinetics immediate-early genes. Genomics (1999) 0.98
A comparative study of amino acid consumption by rat islet cells and the clonal beta-cell line BRIN-BD11 - the functional significance of L-alanine. J Endocrinol (2003) 0.98
Aqueous extracts of husks of Plantago ovata reduce hyperglycaemia in type 1 and type 2 diabetes by inhibition of intestinal glucose absorption. Br J Nutr (2006) 0.97
Insulin-secreting activity of the traditional antidiabetic plant Viscum album (mistletoe). J Endocrinol (1999) 0.95
Parents' accuracy in estimating child weight status. Addict Behav (1990) 0.95
Glycaemic effects of traditional European plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetes Res (1989) 0.95
Specific binding of the C-peptide of proinsulin to cultured B-cells from a transplantable rat islet cell tumor. Biosci Rep (1986) 0.93
Genetic mapping of a pulmonary adenoma resistance (Par1) in mouse. Nat Genet (1996) 0.93
Engineering cultured insulin-secreting pancreatic B-cell lines. J Mol Med (Berl) (1999) 0.93
Determination of the burden of hepatitis C virus infection in Ireland. Epidemiol Infect (2011) 0.92
Immunoreactive gastric inhibitory polypeptide and K cell hyperplasia in obese hyperglycaemic (ob/ob) mice fed high fat and high carbohydrate cafeteria diets. Acta Endocrinol (Copenh) (1986) 0.92
Induction of cytochrome P450III and P450IV family proteins in streptozotocin-induced diabetes. Biochem J (1990) 0.91
Abnormalities of GIP in spontaneous syndromes of obesity and diabetes in mice. Diabetes (1983) 0.91
Comparative effects of GLP-1 and GIP on cAMP production, insulin secretion, and in vivo antidiabetic actions following substitution of Ala8/Ala2 with 2-aminobutyric acid. Arch Biochem Biophys (2004) 0.91
Pancreatic cancer cells selectively stimulate islet beta cells to secrete amylin. Gastroenterology (1998) 0.91
Evaluation of traditional plant treatments for diabetes: studies in streptozotocin diabetic mice. Acta Diabetol Lat (1989) 0.90
Defective expression of cytochrome P450 proteins in the liver of the genetically obese Zucker rat. Eur J Pharmacol (1995) 0.90
Calcium and pancreatic beta-cell function. The mechanism of insulin secretion studied with the aid of lanthanum. Biochem J (1980) 0.90
Na+ cotransport by metabolizable and nonmetabolizable amino acids stimulates a glucose-regulated insulin-secretory response. Biochem Biophys Res Commun (1998) 0.89
Pancreatic and extra-pancreatic effects of the traditional anti-diabetic plant, Medicago sativa (lucerne). Br J Nutr (1997) 0.89
Detrimental actions of metabolic syndrome risk factor, homocysteine, on pancreatic beta-cell glucose metabolism and insulin secretion. J Endocrinol (2006) 0.89
Insulin and glucagon during pentobarbitone anaesthesia. Diabete Metab (1980) 0.89
Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance. Diabetes Obes Metab (2010) 0.89
Evaluation of the insulin-releasing and glucose-lowering effects of GPR120 activation in pancreatic β-cells. Diabetes Obes Metab (2014) 0.89
Development of glucose intolerance and impaired plasma insulin response to glucose in obese hyperglycaemic (ob/ob) mice. Horm Metab Res (1981) 0.88
Effects of copper deficiency and experimental diabetes on tissue antioxidant enzyme levels in rats. Ann Nutr Metab (1994) 0.88
Nature's own pharmacy: the diabetes perspective. Proc Nutr Soc (1997) 0.88
ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line. Diabetes (1999) 0.88
Hormonal control of glucose homeostasis during development and ageing in mice. Metabolism (1982) 0.88
Influence of genetic background and age on the expression of the obese hyperglycaemic syndrome in Aston ob/ob mice. Int J Obes (1982) 0.88
Prognosis following first acute myocardial infarction in Type 2 diabetes: a comparative population study. Diabet Med (2002) 0.88
Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice. Br J Pharmacol (2013) 0.88
Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme. Br J Cancer (2009) 0.87
Antimony distribution and environmental mobility at an historic antimony smelter site, New Zealand. Environ Pollut (2004) 0.87
Assessment of skeletal muscle viability by PET. J Nucl Med (1995) 0.87
Prenatal screening of pregnant women for infections caused by cytomegalovirus, Epstein-Barr virus, herpesvirus, rubella, and Toxoplasma gondii. Am J Obstet Gynecol (1983) 0.87
Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline. Diabetes Obes Metab (2015) 0.86
Enhancement of homocysteine toxicity to insulin-secreting BRIN-BD11 cells in combination with alloxan. J Endocrinol (2012) 0.86
Impaired metabolic function and signaling defects in phagocytic cells in glycogen storage disease type 1b. J Clin Invest (1990) 0.86
Calcium and pancreatic beta-cell function. IX. Demonstration of lanthanide-induced inhibition of insulin secretion independent of modifications in transmembrane Ca2+ fluxes. Endocrinology (1980) 0.86
Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetes. Diabetologia (2012) 0.86
Drugs inducing hypoglycemia. Pharmacol Ther (1989) 0.86
Arterial ligation for severe epistaxis. J Laryngol Otol (1969) 0.86
Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP(3-42), is a GIP receptor antagonist in vivo. J Endocrinol (2002) 0.86
Insulin-releasing and insulin-like activity of Agaricus campestris (mushroom). J Endocrinol (1998) 0.85
Desensitization of sulphonylurea- and nutrient-induced insulin secretion following prolonged treatment with glibenclamide. Eur J Pharmacol (2000) 0.85
Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob/ob) mice. J Endocrinol (1984) 0.85
Detection of glycated gastric inhibitory polypeptide within the intestines of diabetic obese (ob/ob) mice. Endocrine (2001) 0.84
Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet. Int J Obes (Lond) (2010) 0.84
Comparison of the secretory properties of four insulin-secreting cell lines. Endocr Res (2002) 0.84
Effects of a transplantable insulinoma upon regulatory peptide concentrations in the gastrointestinal tract of the rat. Diabetologia (1986) 0.84
Stimulation of insulin secretion in clonal BRIN-BD11 cells by the imidazoline derivatives KU14r and RX801080. Pharmacol Res (2000) 0.84
Modulation of the rat hepatic cytochrome P450 composition by long-term streptozotocin-induced insulin-dependent diabetes. J Biochem Toxicol (1994) 0.83
Effect of RU486 on hepatic and adipocyte gene expression improves diabetes control in obesity-type 2 diabetes. Horm Metab Res (2009) 0.83
Protein synthesis rates of skeletal muscle, lymphocytes, and albumin with stress hormone infusion in healthy man. Metabolism (1996) 0.83
Gastric inhibitory polypeptide and effects of glycation on glucose transport and metabolism in isolated mouse abdominal muscle. J Endocrinol (1998) 0.83
Improved glycaemic control in obese diabetic ob/ob mice using N-terminally modified gastric inhibitory polypeptide. J Endocrinol (2000) 0.83
Stable and efficient gene transfer into the mutant retinal pigment epithelial cells of the Mitf(vit) mouse using a lentiviral vector. Curr Eye Res (1999) 0.83
Glycation of insulin in the islets of Langerhans of normal and diabetic animals. Diabetes (1996) 0.83
High-resolution linkage map of mouse chromosome 13 in the vicinity of the host resistance locus Lgn1. Genomics (1997) 0.83
Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice. Peptides (2007) 0.83
Reduced hypothalamic neurotensin concentrations in the genetically obese diabetic (ob/ob) mouse: possible relationship to obesity. Metabolism (1991) 0.83
Defective regulation of glucokinase in rat pancreatic islet cell tumours. Acta Endocrinol (Copenh) (1987) 0.83
Anorectic effect of fenfluramine, cholecystokinin and neurotensin in genetically obese (ob/ob) mice. Comp Biochem Physiol A Comp Physiol (1986) 0.83
Antihyperglycaemic effect of saccharin in diabetic ob/ob mice. Br J Pharmacol (1997) 0.83
Physiological and pharmacological regulation of insulin release: insights offered through exploitation of insulin-secreting cell lines. Diabetes Obes Metab (1999) 0.83